William J. Caragol, Chairman and Chief Executive Officer
William J. Caragol was appointed Chairman and CEO of PositiveID in 2011, and has served as the company's president since its inception. Mr. Caragol was also CFO of PositiveID from 2007 to 2011, and was previously president and CFO of VeriChip Corporation. Mr. Caragol also served as Steel Vault Corporation's CEO, president and a member of its board of directors. From July 2005 to August 2006, he served as the chief financial officer of Government Telecommunications, Inc., a company under common control with PositiveID at the time. From December 2003 to June 2005, Mr. Caragol was the vice president of business development and chief financial officer of Millivision Technologies, a technology company focused on security applications. Prior to his role at Millivision Technologies, Mr. Caragol was a consulting partner with East Wind Partners LLP, a technology and telecommunications consulting company, in Washington, D.C, and spent eight years at Deloitte and Touche. He is a member of the American Institute of Certified Public Accountants and graduated from the Washington & Lee University with a bachelor of science in Administration and Accounting.
Ambassador Ned L. Siegel
Ambassador Ned L. Siegel has served as a member of our Board of Directors since February 2011. He has served as President of the Siegel Group, Inc. since September 1997, and Managing Member of the Siegel Consulting Group, LLC since November 2009, which provide real estate development and realty management services. From October 2007 until January 2009, he served as United States Ambassador to the Commonwealth of the Bahamas. From September 2006 until January 2007, he served as Senior Advisor to the United States Mission for the 61st Session of the United Nations General Assembly. From January 2003 until October 2007, Mr. Siegel was a member of the Board of Directors of the Overseas Private Investment Corporation. From 2003 until 2007, he served as a member of the Board of Directors of the Caswell-Massey Company, Ltd., a world-wide quality bath and body, home fragrance and gifts company. Mr. Siegel was appointed Vice Chairman of Alternative Fuels Americas, Inc. in January of 2011. Mr. Siegel earned a bachelor of arts degree from the University of Connecticut in 1973 and a juris doctorate from the Dickinson School of Law in 1976. Mr. Siegel was nominated to the Board of Directors due to his past experience with government appointments and services and his managerial experience.
Michael E. Krawitz has served as a member of our Board of Directors since November 2008. He currently serves as chief executive officer of PEAR, LLC, a provider of green retrofitting and renewable energy. From January 2010 until February 2011, he served as chief executive officer of Florida Sunshine Investments I, Inc. He previously served as the chief executive officer and president of Digital Angel Corporation from December 2006 to December 2007, executive vice president from March 2003 until December 2006, and as a member of its Board of Directors from July 2007 until December 2007. Mr. Krawitz served as a member on the Board of Directors of Steel Vault from July 23, 2008 until November 11, 2009. Mr. Krawitz earned a bachelor of arts degree from Cornell University in 1991 and a juris doctorate from Harvard Law School in 1994. Mr. Krawitz was nominated to the Board of Directors due to his past experience as a chief executive officer of Digital Angel, our former parent company, as well as his experience as an attorney.
Jeffrey S. Cobb
Jeffrey S. Cobb has served as a member of our Board of Directors since March 2007. Mr. Cobb is the chief operating officer of IT Resource Solutions.net, Inc. Prior to April 2004, Mr. Cobb was the executive vice president and chief operating officer of SCB Computer Technology Inc. Mr. Cobb served as a member on the Board of Directors of Steel Vault from March 2004 through July 22, 2008. Mr. Cobb earned his Bachelor of Science in Marketing and Management from Jacksonville University. Mr. Cobb was nominated to the Board of Directors because of his management and business development experience in technology companies.
Kimothy Smith, Ph.D., Chief Technology Advisor to MicroFluidic Systems
As current Chief Technology Advisor at PositiveID's Microfluidic Systems, Dr. Kimothy Smith provides professional consulting services in the areas of biosurveillance, bioforensics, biodefense, biosecurity, molecular genetics and diagnostics, and food safety, defense and security. Recently he was as a Senior Scientist for the Tahoe Research Initiative LLC, where he worked internationally on Global Biosurveillance issues to build capacity and capability of public and veterinary health systems. He also served as Director of The Global Resource Initiative, a nonprofit organization that focuses its efforts on bolstering the critical resource base of underserved countries and promoting sustainable agricultural practices. He was promoted to Senior Advisor for International Biodefense for the Department of Homeland Security, Office of Health Affairs and was detailed to the U.S. State Department Office of International Health and Biodefense. Prior to this he served as the Acting Director of the National Biosurveillance Integration Center, where he was responsible for setting the vision and strategy of a U.S. government-wide effort to acquire, aggregate, integrate, analyze, interpret and disseminate all-source biosurveillance information from governmental and private sectors for epidemiological analyses and health protection. Moreover, he was the Department of Homeland Security's first Chief Veterinarian and served as the Chief Scientist for the Office of Health Affairs. Dr. Smith began working for the Department of Homeland Security (DHS) in 2005 where he worked within the Science and Technology Directorate as the Chief of the Research Programs and Countermeasures Office, directing the intramural research program executed through the federal and National Laboratories. Prior to working with DHS, he was at Lawrence Livermore National Laboratory (LLNL) where he served as the Deputy Division Leader for Operations in the Counter-terrorism and Incident Response Division of the Non-proliferation, Arms Control and International Security Directorate. In this capacity Dr. Smith was responsible for maintenance and readiness of the laboratory's nuclear response deployment and assessment teams. Before accepting this appointment, Dr. Smith served as a Deputy Associate Program Leader for the Chemical and Biological National Security Program where he was responsible for administering and managing the portfolio of biodefense research projects at LLNL. He was actively engaged in research execution and program development in the areas of infectious disease ecology, developing molecular typing methods and the application of molecular epidemiological techniques to forensic investigations as an associate professor on the Northern Arizona University (NAU) faculty prior to going to LLNL. He has earned his PhD in molecular epidemiology from Louisiana State University (1999) where he curated the worldwide Bacillus anthraces collection. He earned his BS in Biochemistry and Doctorate of Veterinary Medicine from Oklahoma State University and was a practicing veterinarian for almost 10 years.
Dr. Galassetti is Associate Professor of Pediatrics and Pharmacology at the University of California, Irvine ("UCI"), where he also serves as the Director of the Bionutrition/Metabolism Core at the Institute for Clinical and Translational Science, and as Associate Director of the Pediatric Exercise Research Center. In his role as scientific advisor to PositiveID, Galassetti will contribute his expertise on breath analysis to the development of PositiveID's Breath Glucose Detection(tm) non-invasive breath glucose detection device. Galassetti has focused on developing a novel technology to measure non-invasively a broad range of metabolic variables through exhaled breath analysis, in collaboration with the UCI department of chemistry. A number of previously unstudied gases present in human breath at extremely low concentrations correlated with several key metabolic indicators, including plasma glucose, insulin, lipids, ketones and inflammatory markers, promise the near-future evolution of these measurements into clinically applicable devices. The recipient of several scientific national awards, Galassetti is a member of the editorial board of the Journal of Applied Physiology, acts as a reviewer for about 20 scientific journals, and as a grant reviewer for the NIH, the Juvenile Diabetes Foundation and several international scientific foundations.Yuval Rabin
Yuval Rabin is Managing Partner at Oris Investments and brings on board deep business experience with governments, state and federal processes, and an extensive network and contacts around the globe, including Africa, Arab countries, and Eastern European countries. Rabin lives in Israel, where the Company is currently developing its Breath Glucose Detection(tm) non-invasive breath glucose detection device. Rabin, son of the late Israeli Prime Minister Yitzhak Rabin, was previously a Managing Partner at the Washington, D.C.-based Rabin, Sheves, Lipkin-Shahak, and Birger ("RSLB"), and was one of the first non-Americans to lobby the U.S. administration on behalf of foreign countries. Prior to RSLB, Rabin held senior executive positions serving companies including AARP, The Principal Group, Ericsson, Airbus Industries, Nokia and Samsung among others. Rabin has also led initiatives for manufacturing and service companies, utilities and governments in the U.S., Israel, Europe and the Far East. Rabin is a veteran of the Israel Defense Forces, having achieved the rank of major during his eight years of service.